Atticus Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7
| Closed | -$2.3K | – | 517 |
|
|
2024
Q4 | $2.3K | Hold |
7
| – | – | ﹤0.01% | 461 |
|
|
2024
Q3 | $2.34K | Hold |
7
| – | – | ﹤0.01% | 460 |
|
|
2024
Q2 | $1.91K | Hold |
7
| – | – | ﹤0.01% | 463 |
|
|
2024
Q1 | $2.42K | Hold |
7
| – | – | ﹤0.01% | 470 |
|
|
2023
Q4 | $2.26K | Hold |
7
| – | – | ﹤0.01% | 478 |
|
|
2023
Q3 | $2.51K | Hold |
7
| – | – | ﹤0.01% | 487 |
|
|
2023
Q2 | $2.65K | Hold |
7
| – | – | ﹤0.01% | 476 |
|
|
2023
Q1 | $3.35K | Buy |
7
+2
| +40% | +$958 | ﹤0.01% | 451 |
|
|
2022
Q4 | $2.1K | Sell |
5
-7
| -58% | -$2.94K | ﹤0.01% | 461 |
|
|
2022
Q3 | $6K | Hold |
12
| – | – | ﹤0.01% | 417 |
|
|
2022
Q2 | $6K | Sell |
12
-93
| -89% | -$46.5K | ﹤0.01% | 448 |
|
|
2022
Q1 | $59K | Sell |
105
-17
| -14% | -$9.55K | 0.02% | 231 |
|
|
2021
Q4 | $92K | Sell |
122
-112
| -48% | -$84.5K | 0.04% | 177 |
|
|
2021
Q3 | $175K | Buy |
234
+95
| +68% | +$71K | 0.08% | 110 |
|
|
2021
Q2 | $90K | Buy |
139
+14
| +11% | +$9.07K | 0.04% | 180 |
|
|
2021
Q1 | $71K | Buy |
125
+86
| +221% | +$48.8K | 0.03% | 179 |
|
|
2020
Q4 | $23K | Buy |
39
+37
| +1,850% | +$21.8K | 0.01% | 252 |
|
|
2020
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 296 |
|